ESR1 and breast cancer: In NCT03846167, four breast cancer patients with invasive ductal carcinoma (stage III/IV, 3 triple-negative and 1 estrogen receptor-positive) underwent [18F]FTT PET/CT imaging pre- and one week post-PARPi treatment (Figure 4C) [81].